Principal Investigator
Byron Lam
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240331
Clinical Trial Summary
Open-label, Single Ascending Dose Study to
Evaluate the Safety, Tolerability, and Preliminary
Efficacy of Sub retinal ACDN-01 in Participants with
ABCA4-related Retinopathy
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other